Valeant Pharmaceuticals International Principal Designer Salaries in Wilmington, DE
The average Valeant Pharmaceuticals International Principal Designer in Wilmington, DE earns an estimated $168,175 annually, which includes an estimated base salary of $144,856 with a $23,319 bonus. Valeant Pharmaceuticals International's Principal Designer compensation is $25,610 more than the US average for a Principal Designer. Principal Designer salaries at Valeant Pharmaceuticals International in Wilmington, DE can range from $70,000 - $300,000.
In Wilmington, DE, The Design Department at Valeant Pharmaceuticals International earns $4,860 more on average than the HR Department.
Last updated 2 years ago.
- $144,856
- avg. base
- $23,319
- avg. bonus
Principal Designer Salaries at Valeant Pharmaceuticals International
In Wilmington, DE, Principal Designers earn $2,345 more than Creative Directors.
Compensation at Valeant Pharmaceuticals International by Department
In Wilmington, DE, The Design Department averages $4,860 more than the HR Department, and $5,956 less than the Sales Department
Principal Designer Compensation by Gender (All Companies)
The average female Principal Designer at companies similar size to Valeant Pharmaceuticals International reported making $154,148, while the average male Principal Designer at similar sized companies reported making $175,977.
Principal Designer Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Principal Designer at companies similar size to Valeant Pharmaceuticals International reported making $174,333, while the average African American/Black Principal Designer at similar sized companies reported making $134,000.
How Principal Designers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Principal Designers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Principal Designers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
